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Background: At present there is no established national minimum data set (MDS) for generic wound
assessment in England, which has led to a lack of standardisation and variable assessment criteria being
used across the country. This hampers the quality and monitoring of wound healing progress and
treatment.
Aim: To establish a generic wound assessment MDS to underpin clinical practice.
Method: The project comprised 1) a literature review to provide an overview of wound assessment best
practice and identify potential assessment criteria for inclusion in the MDS and 2) a structured consensus
study using an adapted Research and Development/University of California at Los Angeles Appropri-
ateness method. This incorporated experts in the wound care ﬁeld considering the evidence of a liter-
ature review and their experience to agree the assessment criteria to be included in the MDS.
Results: The literature review identiﬁed 24 papers that contained criteria which might be considered as
part of generic wound assessment. From these papers 68 potential assessment items were identiﬁed and
the expert group agreed that 37 (relating to general health information, baseline wound information,
wound assessment parameters, wound symptoms and specialists) should be included in the MDS.
Discussion: Using a structured approach we have developed a generic wound assessment MDS to un-
derpin wound assessment documentation and practice. It is anticipated that the MDS will facilitate a).
ier Ltd on behalf of Tissue Viability Society. This is an open access article under the CC BY-NC-ND license (http://
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MDS Minimum Data Set
CQUIN Commissioning for Quality and
NHS National Health Service
ABPI Ankle Brachial Pressure Indexmore consistent approach to generic wound assessment practice and support providers and commis-
sioners of care to develop and re-focus services that promote improvements in wound care.
© 2017 The Authors. Published by Elsevier Ltd on behalf of Tissue Viability Society. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Innovation1. Background
Chronic wounds, sometimes referred to as ‘difﬁcult to heal’
wounds are usually deﬁned in relation to wound duration with
parameters of 4e12 weeks being used [1e4]. Chronic wounds,
which commonly incorporate pressure ulcers, venous ulcers, arte-
rial ulcers and diabetic ulcers represent a signiﬁcant burden to
patients and health care providers worldwide. It is estimated that
almost 1% of the worlds population experiences difﬁcult to heal
wounds which are associated with negative quality of life [5]. In the
United States, chronic wounds affect approximately 6.5 million
patients with an estimated $25 billion treatment cost per annum
[6]. This is also reﬂected in the United Kingdom where recent in-
formation from the Health Improvement Network (THIN) Database
which collects data from primary care, indicated 4.5% (2.2 million)
of the adult populationwere estimated to have a wound (excluding
surgical wounds that healed within 4 weeks of the procedure) in
2012/13, accounting for 40.6 million healthcare professional/pa-
tient visits, 97.1 million drug prescriptions, 344.6 million dressings/
bandages and costing £4.5e5.1 billion [7]. The study also found that
12% of wounds had no recorded diagnosis and 56% of the wounds
recoded as leg ulcers lacked a differential diagnosis, suggesting a
lack of evidence-based wound care/assessment [7]. This is a sub-
stantial problem to the NHS and an important part of nursing
practice.
At present there is no established national minimum data set
(MDS) for generic wound assessment, which has led to a lack of
standardisation and variable criteria being used across England.
This is particularly important for difﬁcult to heal or chronic wounds
as the lack of standardisation hampers decision making about
diagnosis and treatment as well as the quality and monitoring of
wound healing progress. Work to establish an MDS for generic
wound assessment was taken forward as part of NHS England's
Leading Change Adding Value Framework - Improving Wound Care
Project. This aims to underpin wound assessment practice and to
support commissioners and providers in developing and re-
focussing services that promote improvements in wound care.
The work is supported by a new quality indicator for improving the
assessment of wounds as part of the 2017-19 Commissioning for
Quality and Innovation (CQUIN) framework [8]. The Improving
Wound Care Project is led by a Board (Fig. 1) which provides
oversight for the development of the generic wound assessment
MDS. The project incorporates:
1) A literature review to identify potential assessment criteria for
the MDS and;2) A structured consensus study to agree the assessment criteria to
be included in the MDS to facilitate a standardised approach to
wound assessment practice.
The Board is supported by a generic wound assessment MDS
sub-group to provide focussed advice on this project, an ‘expert by
experience group’ to provide the service-user and clinical user
perspective and the consensus study expert group to agree the
assessment criteria to be included in the MDS (Fig. 1).2. Literature review
2.1. Method
A literature review was undertaken to identify potential
assessment criteria to be included in the MDS. The review consid-
ered any literature relating to wound assessment criteria and was
not limited by any particular study design and incorporated guid-
ance papers [9]. A simple key word search (chronic wound,
assessment, management, validity, reliability, guideline, docu-
mentation) of the MEDLINE database (Jan 1996eAug 2016) was
undertaken using Boolean operators ‘and’ ‘or’. Citations of relevant
studies were also considered.
The abstracts of these papers were screened to identify those
which potentially provided comprehensive information about
criteria considered when conducting wound assessment. Papers
considered potentially relevant were reviewed in full by the
researcher (SC). The wound assessment criteria contained in rele-
vant papers were extracted andmapped against wound assessment
domains (key assessment areas) and sub-domains (detailed
assessment concepts). The initial framework for the domains and
sub-domains were informed by the generic wound assessment
MDS sub-group (Fig. 1). These were amended as new concepts
emerged from the literature review and the ﬁnal domains and sub-
domains were reviewed and agreed by the Improving Wound Care
project Board.2.2. Results
The search identiﬁed over 300 papers, of which 24 identiﬁed
wound assessment domains and sub-domains incorporating the
following papers types:
 9 wound healing/monitoring instruments [10e18].
 10 wound assessment guidance [19e28].
 2 primary wound care studies [29,30].
 2 literature/systematic review [31,32]. The systematic review
provided citations for other wound assessment instruments
included in this review.
 1 wound care quality improvement initiative [33].
Table 1 provides a summary of ﬁndings indicating 6 key do-
mains comprising general health information wound history/
baseline information, wound assessment parameters, wound
symptoms, infection and specialist information and an associated
69 sub-domains. Most of these sub-domains were considered po-
tential assessment criteria in the subsequent consensus study.
Fig. 1. Groups involved in the development of the Generic Wound Assessment MDS.
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3.1. Methods
A modiﬁed RAND/UCLA (Research and Development/University
of California at Los Angeles) appropriateness method [34] based on
a previous consensus study was used [35]. This incorporated face-
to-face interaction of an expert group and pre- and post- meeting
questionnaire completion (incorporating 9 point Likert scales)
considering what should be included in a generic wound assess-
ment MDS.3.2. Sample
Participants forming the expert group were purposefully
sampled to incorporate multi-speciality clinical/academic leaders
in the wound care ﬁeld, identiﬁed by their previous work and/or
related publications [36]. Seventeen members were recruited to
allow for attrition and to maximize reliability while preventing
facilitation problems [37].3.3. Ethical considerations
The study was reviewed and approved by a University of Leeds
Research Ethics Committee. Prior to recruitment expert group
members were provided with a study information sheet and
encouraged to ask questions. Following this informed consent was
sought by the researcher (SC).3.4. Data collection
The initial literature review provided the framework for the pre
and post meeting questionnaires which were developed to seek
expert group members' individual views regarding the important
elements to be included in the MDS. The questionnaires incorpo-
rated statements relating to potential assessment criteria and
participants were asked to reﬂect on the results of the literature
review and their clinical experience and/or expertise in the ﬁeld
when rating their level of support for including these in theMDS on
a 9 point Likert scale (where 1 indicates poor support and 9 in-
dicates strong support).
The questionnaires comprised fewer items than the sub-
domains identiﬁed in literature review because the primary pa-
pers did not always specify the underlying concept being consid-
ered e.g. ‘none speciﬁc exudate’ sub-domain (did not specify
whether this related to amount, consistency or something else). In
contrast some sub-domains were excluded because they were
considered too speciﬁc for the MDS andwere only encountered in a
few primary studies of the literature review, e.g. ‘quality of life,
social e hobbies’. Pre and post meeting questionnaire completion
was undertaken to allow individuals to change their ratings in light
of discussions and/or where necessary for questionnaire items to be
clariﬁed and amended.
The face-to-face meeting was undertaken in a pleasant hotel
setting and refreshments were provided throughout. The meeting
was facilitated by the researcher (SC) to ensure all members had the
opportunity to discuss their opinions [37]. The focus of the meeting
was discussing the scope of the MDS and reviewing the results of
the pre-meeting questionnaire. This allowed areas of disagreement
and uncertainty to be discussed and for members to consider this
before privately re-rating their level of support in the post-meeting
questionnaire.
Table 1
Wound assessment domains and sub-domains (potential assessment criteria) included in papers of the literature review.
Domain Sub-domain Of 24 papers
General health information Allergies 3
Mobility Status 2
Risk Factors for Delayed Healing
Factors affecting systemic blood supply to wound (e.g.
vascular or arterial disease, smoking, anaemia)
10
Factors affecting local blood supply to wound (e.g. pressure/
shear, pressure ulcer)
8
Factors affecting skin (e.g. malnutrition, obesity, peripheral
neuropathy)
10
Susceptibility to infection (e.g. immune-supressed) 10
Medication affecting wound healing (e.g. steroids,
chemotherapy)
9
Generic delayed healing (non-speciﬁc) 2
Quality of life
Patient Information 2
Physical - Fatigue/lack of sleep 1
Physical - Reduced mobility 2
Physical- Health and wellbeing 2
Physical - Changes to eating habits 1
Physical- Daily activities 2
Emotional e Depression 1
Emotional e Emotions 2
Social- Friendships 2
Social e Hobbies 1
Social - Frequency of dressing changes 1
Social- Pain 1
Social e Odour 1
Social- Social isolation 2
Non-speciﬁc 1
Wound history/baseline information Number of wounds 6
Wound Location 14
Wound type/classiﬁcation (e.g., venous leg ulcer, pressure
ulcer)
16
Wound Duration (e.g. weeks, months, years) 8
Wound assessment parameters Wound size width 19
Wound size length 19
Wound size (non-speciﬁc) 1
Wounds size depth 21
Undermining/tunnelling 16
Shape 3
Wound bed tissue type (e.g. necrotic, sloughy) 20
Wound bed tissue amount (e.g. percentage of wound) 11
Wound bed (non- speciﬁc) 1
Wound margins/edges description (e.g. epithelialisation
undermining)
17
Wound margins/edges (non-speciﬁc) 1
Surrounding skin colour (e.g. redness) 17
Surrounding skin condition (e.g. maceration, oedema,
induration)
16
Surrounding skin (non-speciﬁc) 2
Current wound status (e.g. progress/deterioration) 12
Wound symptoms Pain frequency (e.g. at dressing change) 11
Pain severity 11
Pain (non-speciﬁc) 4
type (i.e. inﬂammatory neuropathic) 2
Full pain assessment 5
Current pain status (progress/change) 4
Exudate amount (e.g. high, moderate) 18
Exudate consistency/type/colour (e.g. serous, blood, sero-
sanguineous, thick, thin)
16
Exudate (non-speciﬁc) 1
Current exudate status (progress/deterioration) 5
Exudate problem to patient 1
The performance of the current dressing in absorbing
wound exudate
10
Odour occurrence (e.g. on dressing removal, when dressing
intact)
9
Odour intensity (e.g. acceptable
minimal, problem)
4
Odour (non-speciﬁc) 2
Current odour status (progress/changes) 5
Odour problem to patient 1
(continued on next page)
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Table 1 (continued )
Domain Sub-domain Of 24 papers
Infection Signs of local wound infection (e.g. cellulitis, abscess/pus,
increasing pain, exudate, odour; deterioration (wound
breakdown and dehiscence), healing slower than
anticipated, friable granulation tissue, bleeds easily,
pocketing at wound base)
16
Signs of systemic infection relating to the wound (e.g. high
temp)
4
Management of infection 6
Specialist Information Tissue viability team referrals 0
Hospital consultant referrals (e.g. vascular, plastics) 0
Pressure ulcer risk assessment 8
Doppler ABPI 5
S. Coleman et al. / Journal of Tissue Viability 26 (2017) 226e2402303.5. Analysis
Questionnaire statements were summarised using the median
group response and categorised into tertiles, 1e3 disagree, 4e6
uncertain, 7e9 agree. Within-group agreement was measured us-
ing the RAND Disagreement index [34], which considers the
dispersion of individual scores and identiﬁes areas of disagreement
(where panellists rate at both ends of the Likert Scale). Using the
group median response and the disagreement index for each
statement the following principles were applied following post
meeting questionnaire completion to identify MDS items:
 Group medians of 1e3 without disagreement will be excluded
 Group medians of 7e9 without disagreement will be included
 Disagreement index is >1 or median 4e6 will be excluded but
are potential areas for further research
A directed content analysis approach [38] was used to code data
from transcripts of the expert group meetings and a summary
report was written and checked for accuracy the expert group.
3.6. Results
Expert group members comprised nurses and Doctors with a
wound care interest (Fig. 1) and incorporated 2 males and 15 fe-
males. All seventeen members fully completed the pre-meeting
questionnaire. Sixteen members attended the face-to-face
meeting and fully completed the post-meeting questionnaire.
The expert group indicated their support for inclusion of 42 of
the 46 MDS items (Table 2) included in the pre-meeting ques-
tionnaire (with one area of disagreement relating to odour status)
and 4 areas of uncertainty (quality of life (physical, social and
emotional) and pressure ulcer risk assessment).
The discussions at the face-to-facemeeting (Table 3) led to some
changes in opinion and amendments to the post-meeting ques-
tionnaire which incorporated 47 items. The amendments related to
requested additional items of skin sensitivities, wound location,
treatment aim, re-assessment date, pressure ulcer category, healing
and some items being combined (all noted by italics in Table 2). The
results of the post-meeting questionnaire indicated there was
support for 33 items with a group median of 7e9 (without
disagreement), lack of support for 7 items, uncertainty about 4
items, 1 item with a median of 8 but with disagreement, 2 items
where the median fell in-between 2 tertiles.
Table 3 provides a summary of the speciﬁc assessment item and
MDS implementation discussion points.
4. Further consultation
The Improving Wound Care Project Board (Fig. 1) met to discussthe results and drawing on the thematic summary (Table 3) it was
agreed that an additional post-meeting follow-up questionnaire
would be sent to the expert group to seek clarity on the itemwith a
median of 3.5 (allergies), the item with a median of 8 with
disagreement (signs of systemic infection) and an additional pain
item. This led to the inclusion of these items (Table 2). In addition,
the Board agreed that ‘factors affecting the patient's skin integrity’
should be recorded in the MDS. Table 4 provides a summary of the
agreed generic wound assessment MDS comprising 37 items.
Further consultation about the MDS was also undertaken with
the ‘Expert by Experience’ Group which was brought together to
support the Improving Wound Care Project and comprised service
users and practising District Nurses and Practice Nurses (Fig. 1). The
group were supportive of the MDS and particularly about the in-
clusion of the quality of life item as they saw this as an opportunity
for the patient to express the impact of the wound on their life and
raise any issues that needed to be addressed as part of their
treatment plan. The group also considered the use of photography
to be a useful way of monitoring wound progress.
5. Discussion
This project comprising a literature review and a consensus
study was undertaken to establish a generic wound assessment
MDS. The literature review identiﬁed 6 key domains and 69 sub-
domains relating to wound assessment. This underpinned the
development of consensus questionnaires comprising 46 (pre-
meeting) and 47 (post-meeting) items that were considered by an
expert group and led to the agreement of 37 items in the generic
wound assessment MDS (Table 4).
In keeping with those who used structured consensus methods
in the development of pressure ulcer risk assessment MDS [35], the
method provided a transparent approach to the development of a
generic wound assessment MDS, informed, in this case by a liter-
ature review (rather than a more robust systematic review) and the
opinions of experts in the ﬁeld. The discussions of the expert group
face-to-face meeting allowed challenges and differences in opinion
to be explored and understood. This highlighted the different ap-
proaches to wound assessment and the complexities of stand-
ardising this variation across different systems for patient records
including paper-based, electronic and various combinations of the
two. Avoiding duplication between the MDS and the standard ho-
listic patient assessment was recognised as a challenge given the
differing approaches being used. This led to some ﬂexibility where
it was agreed that some items should be recorded in the MDS if not
recorded in wider the patient record e.g. allergies, quality of life.
Another important discussion point of the expert group and expert
by experience group related to the use of photography for wound
assessment and monitoring purposes. Due to recognition of the
varying availability of high quality cameras in clinical practice, the
Table 2
Questionnaire results.
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recognised as good practice, something which should be encour-
aged and could potentially be included in the MDS in the future.
The MDS was developed using a bottom-up manner involving
predominantly clinical practitioners with facilitation by policy
makers (NHS England) and academia. This approach enabled aca-
demic scientiﬁc theoretical knowledge to be balanced with tech-
nical knowledge and practical wisdom from clinical practice to
inform the MDS. The resulting MDS is therefore more likely to be
acceptable and usable in clinical practice. The decision to focus on a
MDS rather than seeking to develop a pre-speciﬁed assessment
form also allows ﬂexibility. Many healthcare providers will already
use a wound assessment form that incorporate many or all of the
items in the MDS. The MDS will allow review of existing docu-
mentation systems against a set of evidence-based criteria to assess
whether supplementation or simpliﬁcation is required.
The development of the MDS has sought to address concerns
over inadequate wound assessment practice [7] by providing a
framework upon which healthcare provider organisations can base
their assessment documentation. However, the MDS can only
provide a starting point for improving care and measures to
encourage implementation are needed. The MDS will be supported
by a guidance manual for practice, sample assessment forms and a
speciﬁc CQUIN to monitor progress. It is anticipated that the MDS
will facilitate a more consistent approach to wound assessment
potentially leading to improved subsequent t clinical decision
making about wound care treatment, escalation plans, pathways
and patient outcomes. The MDS may lead to the development of
large NHS data-sets that can be used for research and to monitor
wound care practice and service improvements. It could provide a
more consistent approach to the recording characteristics of futurewound care studies [39], facilitating the possibility combining the
results of different studies and meta eanalysis to provide a more
robust evidence-base in the ﬁeld.
The development of the MDS is only one important component
of the Improving Wound Care Project and other work streams
including React to Red, Education& Competencies andWound Care
Commissioning Support (Primary Care & Community Services) all
have a role to play in supporting improvements in wound care
practice. Of particular note is the need for further development of
more specialist assessment MDS for speciﬁc types of wounds such
as those of the lower limb.
5.1. Limitations
The literature review was undertaken by one reviewer and only
incorporated the search of one database over limited years, with
the potential that a more systematic scoping review may have
identiﬁed additional relevant studies. However, given that the
literature review aimed to identify potential items for inclusion in
the MDS (rather than identifying every paper that considered
wound assessment parameters) and we drew on the collective
wisdom of experts in the wound care ﬁeld throughout the
consensus process, it seems unlikely that any important aspects of
wound assessment would have been missed.
Another area of concern relates to limited service user
involvement in this study. While other consensus studies have
incorporated limited numbers of patients/carers in their expert
groups [40,41], we used a different approach in an effort to avoid
under-representation of service user views [35] and some of the
problems associated with reviewing complex information and
facilitating mixed groups of professionals and patients [42]. This
Table 3
Summary of discussions.
Potential Assessment Criteria Summary of Discussion
Allergies -Acknowledged as an important consideration but debate about duplication
-Concern from a medico-legal perspective and that it should be included.
-Concern that nurses focus on generic allergies to medications rather than wound care speciﬁc allergies (e.g.
dressings, emollients, tapes).
Sensitivities -Concern that while many patients may not be technically allergic to a particular product or dressing the may
have sensitivities (e.g. they may complain of itchiness or redness) which should be considered.
Risk Factors for delayed healing -Duplication concerns but considered important in the wound care context to inform treatment.
-Concern that lack of education, knowledge and research in this area could make it difﬁcult for nurses to make
the link between delayed healing risk factors and wound assessment and that prompts to facilitate this were
needed.
-Suggested that risk factors for delayed healing should be broken down to systemic and local blood supply to the
wound, skin integrity, susceptibility to infection and medication to prompt their consideration
Quality of Life (QOL) -Duplication concerns but the need to ensure patient centeredness was emphasised.
-Noted that in patients with multiple co-morbidities it was sometimes difﬁcult to separate wound-speciﬁc QOL
issues from wider illnesses.
Number of wounds -Acknowledged as important but in practice a separate wound assessment form would be used for each wound.
Wound type/classiﬁcation -Recognised as being particularly important in informing appropriate treatment.
Wound Location -Important in informing the wound type (e.g. lower limb wounds may prompt the nurse to consider the
possibility of a leg ulcer).
Wound duration -Acknowledged as important in informing ongoing treatment and referrals.
-The date of ﬁrst wounding was considered important for continuity and preventing ‘everybody starting at the
beginning again’ and failing to recognised the long-standing nature of a particular wound.
-The duration of the wound can be calculated from date of ﬁrst wounding.
-Digital health records may allow automated ﬂagging of non-healing wounds after speciﬁc time periods to
prompt further action.
Treatment aim -Acknowledged as important as some wounds are unlikely to heal.
Reassessment -A date to prompt reassessment was considered important.
Referrals -Considered important in demonstrating pathway compliance e.g. referral to specialist if non-healing after to
speciﬁc time period.
Wound size -Length, width and depth of a wound considered of paramount importance in being able monitor improvement,
deterioration and failure of wounds to heal.
-The need for consistent and accurate wound measurement undertaken at the maximum part of the wound for
each parameter was highlighted.
-The method used for wound measurement and body maps was a matter for local policy.
-Overall the shape of the wound was not considered to be important to be included in the MDS as the other
measurements were considered sufﬁcient.
-The category of pressure ulcers should be noted.
Wound Bed
Tissue Type
-Recognised as providing an assessment of the healing continuum and as providing the basis for treatment
decisions.
-Prompts would be needed to describe the wound bed (necrotic, sloughy, granulating, epithelialisation, tendon,
bone)
-This could be simpliﬁed by using colour descriptors of the wound bed.
-High quality photography should be encouraged but could not replace existing assessment parameters.
Wound Bed
Tissue amount
-Tissue amount (as well as type) was considered important as it may prompt further actions i.e. if a wound
changed from having a little slough to being fully sloughy then a change in care would be needed.
-Overall the group leaned towards the use of percentage measurement for quantifying tissue amount but noted
the need for education and guidance.
Description of wound margins -Considered important in the ongoing monitoring of the wound particularly relating to the colour and condition
of the surrounding skin.
Current overall wound status and healing -Concern was raised about the subjectivity of the overall wound status item.
-Other wound assessment items provide more objective measures of improvement/deterioration.
-Need to record whether a wound had healed as a key outcome.
Pain -Suggested that one leading item was needed about whether they had wound pain or not, which could lead to
other items i.e. frequency and severity.
-Acknowledged that some areas use speciﬁc pain care plans with metrics and there was concern about
duplication for some pain items.
-It was also noted that we needed to make it clear that the assessment related to ‘wound pain’ rather than other
pain.
Exudate -Overall the ‘exudate amount’ item was considered to provide an objective measure of wound response (which
would be informed by dressing performance).
-The item relating to whether exudate was a problem to the patient was considered redundant as exudate was
always an issue and is addressed in the other items.
-The current exudate item was not considered an objective measure.
Odour -Recognised odour as a very important symptom, particularly relating to a sign of infection (especially in the
presence of increasing exudate and pain),
-Also acknowledged as being very subjective measure with a lack of a reliable tool to assist with odour
measurement in practice.
-Patient (or carer/family) concerns were the most important consideration.
- Suggested that only the presence of odour item was needed in the MDS.
Referrals - Considered important in demonstrating pathway compliance e.g. referral to specialist if non-healing after to
speciﬁc time period.
Pressure Ulcer Risk Assessment - Concern about duplication
- Thought to be more relevant to the holistic patient assessment as undertaken on all patient to facilitate
prevention.
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Table 4
Generic wound assessment minimum data set.
Domains Core Generic Wound Assessment Minimum Data Set
General Health Information - Risk factors for delayed healing (systemic and local blood supply to the wound, susceptibility to
infection, medication affecting wound healing, skin integrity)
- aAllergies
- Skin sensitivities
- aImpact of the wound on quality of life (physical, social & emotional)
- Information provided to patient and carers
Wound Baseline Information - Number of wounds
- Wound location
- Wound type/classiﬁcation
- Wound duration
- Treatment aim
- Planned re-assessment date
Wound Assessment Parameters - Wound size (maximum length, width and depth)
- Undermining/tunnelling
- Category (pressure ulcers only)
- Wound bed tissue type
- Wound bed tissue amount
- Description of wound margins/edges
- Colour and condition of surrounding skin
- Whether the wound has healed
Wound Symptoms - Presence of wound pain
- Wound pain frequency
- Wound pain severity
- Exudate amount
- Exudate consistency/type/colour
- Odour occurrence
- aSigns of systemic infection
- Signs of local wound infection
- Whether a wound swab has been taken
Specialists - Investigation for lower limb (ABPI)
- Referrals (TVT, Hospital Consultants)
a Should be recorded in generic wound assessment MDS if not recorded in wider the patient record.
Table 3 (continued )
Potential Assessment Criteria Summary of Discussion
Specialists - Generic assessment should prompt consideration of a Doppler for wounds on the lower limb (when
appropriate), to facilitate a diagnosis and guide subsequent treatment/referral pathways.
- The appropriateness of undertaking a Doppler should be informed by the holistic assessment of the patient.
- The inclusion of a Doppler could be usefully included to prompt a second tier more specialised assessment of
the lower limb.
MDS Scope and Implementation Issues - Acknowledged that the MDS would be supported by appropriate clinical policies.
- Concerns about duplication between information in the standard holistic patient assessment and MDS.
- Recognised that those with electronic records may be able to pull through information of relevance to the
wound assessment from the wider patient assessment.
- Acknowledged that there is great variation in the implementation of electronic records and that the MDS
would need to work for both electronic and paper-based systems.
- Envisaged that the MDS should facilitate clinical decision making and raise early warning of potential wound
healing problems.
S. Coleman et al. / Journal of Tissue Viability 26 (2017) 226e240 235involved consultation with the ‘expert by experience group’
following the consensus process. Unfortunately despite best efforts,
there were difﬁculties in identifying patients/carers who were able
to join the group and only one service user representative was
involved. Increased numbers of service users may have identiﬁed
additional important issues to inﬂuence the ﬁnal MDS. In addition,
it could be argued that the involvement of patients and carers
earlier in the consensus process would have facilitated increased
integration of their views to shape the MDS. Involving patients in
research of crossespeciality problems has been identiﬁed as chal-
lenging due to lack of support infrastructure and the complex
health needs of potential participants [42]. TheWound Care Project
Board are committed to increasing service user involvement
through a range of methods in the wider programme of work.6. Conclusion
Using structured consensus methods that incorporated a liter-
ature review and expert opinion we have developed an MDS to
underpin wound assessment documentation and practice. It is
anticipated that the MDS will facilitate a more consistent approach
to generic wound assessment practice and support providers and
commissioners of care to develop and re focus services that pro-
mote improvements inwound care with the potential for improved
patient outcomes. Future research is needed to conﬁrm this.
Appendix 1. Detailed Wound assessment sub-domains
included in papers of literature review
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